提高糖化血红蛋白达标时间可减少老年糖尿病患者不良健康结局
该回顾性观察研究纳入402,043名≥65岁、有糖尿病且基线3年内至少检测4次A1C的退伍军人,评估个体化A1C目标范围内时间百分比(A1C TIR)与死亡和心血管疾病的关系。平均随访5.5年发现,A1C TIR与死亡和CVD呈分级关系,低A1C TIR与死亡和CVD风险增加相关。
要点
- 在老年糖尿病患者中,A1C TIR与死亡率和心血管疾病风险呈分级负相关。
- 与A1C TIR 80-100%相比,A1C TIR 0-<20%者死亡风险增加(HR 1.22,95%CI 1.20-1.25)。
- 保持A1C在个体化目标范围内与较低的死亡和CVD风险相关。
核心结论
- 在老年糖尿病患者中,维持A1C水平在个体化目标范围内与较低的死亡和心血管疾病风险相关。
研究设计与样本
- 回顾性观察研究,使用2004至2016年美国退伍军人事务部和Medicare行政数据。
- 纳入≥65岁糖尿病患者,基线3年内至少检测4次A1C,共402,043名退伍军人(平均年龄76.9岁,98.8%男性)。
主要发现
- 平均随访5.5年,A1C TIR与死亡率和CVD呈分级关系。
- 与A1C TIR 80-100%相比,A1C TIR 0-<20%者死亡率风险增加(HR 1.22,95%CI 1.20-1.25)。
- 与A1C TIR 80-100%相比,A1C TIR 0-<20%者CVD风险增加(HR 1.14,95%CI 1.11-1.19)。
- 竞争风险模型和较短随访(如24个月)显示相似结果。
关键数值与推荐
- A1C TIR定义为基线期间A1C处于个体化目标范围(6.0-7.0%至8.0-9.0%)的天数百分比。
- 个体化目标范围基于临床特征和预测预期寿命确定。
- A1C TIR按20%增量分类。
临床怎么用
- 对老年糖尿病患者,可基于临床特征和预期寿命设定个体化A1C目标范围。
- 监测A1C TIR可能有助于评估血糖控制稳定性及不良结局风险。
局限性
- 回顾性观察研究设计,无法确立因果关系。
- 研究人群以男性退伍军人为主(98.8%),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Short- and long-term glycemic variability are risk factors for diabetes complications. However, there are no validated A1C target ranges or measures of A1C stability in older adults. We evaluated the association of a patient-specific A1C variability measure, A1C time in range (A1C TIR), on major adverse outcomes. RESEARCH DESIGN AND METHODS: We conducted a retrospective observational study using administrative data from the Department of Veterans Affairs and Medicare from 2004 to 2016. Patients were ≥65 years old, had diabetes, and had at least four A1C tests during a 3-year baseline period. A1C TIR was the percentage of days during the baseline in which A1C was in an individualized target range (6.0-7.0% up to 8.0-9.0%) on the basis of clinical characteristics and predicted life expectancy. Increasing A1C TIR was divided into categories of 20% increments and linked to mortality and cardiovascular disease (CVD) (i.e., myocardial infarction, stroke). RESULTS: The study included 402,043 veterans (mean [SD] age 76.9 [5.7] years, 98.8% male). During an average of 5.5 years of follow-up, A1C TIR had a graded relationship with mortality and CVD. Cox proportional hazards models showed that lower A1C TIR was associated with increased mortality (A1C TIR 0 to <20%: hazard ratio [HR] 1.22 [95% CI 1.20-1.25]) and CVD (A1C TIR 0 to <20%: HR 1.14 [95% CI 1.11-1.19]) compared with A1C TIR 80-100%. Competing risk models and shorter follow-up (e.g., 24 months) showed similar results. CONCLUSIONS: In older adults with diabetes, maintaining A1C levels within individualized target ranges is associated with lower risk of mortality and CVD.
引用
- Prentice JC, Mohr DC, Zhang L, et al. Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes. Diabetes Care. 2021. PMID: 34127496. doi:10.2337/dc21-0292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。